Alexa Craig, MD
Adult & Pediatric Neurology
- Treatment of seizures in newborns as a modifiable risk factor affecting developmental outcomes
- Developmental impact of aggressive treatment of neonatal seizures
Dr. Craig is a pediatric neurologist and clinical researcher whose work focuses on the treatment of seizures in newborns as a modifiable risk factor affecting developmental outcomes. She received a Masters in Science at Bath University in Health Psychology and an MD from the University of Vermont College of Medicine in 2006. She completed a pediatric residency at Maine Medical Center, an additional residency in Child Neurology at the University of Washington and Seattle Children’s Hospital, and a fellowship in Neonatal Neurology at Washington University.
Dr. Craig’s primary research interest focus on the treatment of seizures in newborns as a modifiable risk factor affecting developmental outcomes. She is currently developing a research project which aims to assess the developmental impact of aggressive treatment of neonatal seizures. She is also collaborating with researchers at the University of New England to study motor movements in prematurely born infants and the early prediction of cerebral palsy.
In addition, Dr, Craig is working on a project in the Neonatal Intensive Care Unit that aims to standardize the evaluation of neonatal encephalopathy resulting in improved use of therapeutic hypothermia to prevent brain injury.